Eliyahu Sharon Kalif, EVP, Chief Financial Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 345,810 shares at $33.64 ($11.6M) on 2026-02-26, disclosed to the SEC on 2026-03-02.
Scheduled sale ($11.6M) by EVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TEVA | SELL | 2025-06-16 | $1.9M | — | Filing → |
| TEVA | SELL | 2025-03-04 | $1.8M | — | Filing → |
| TEVA | SELL | 2024-03-07 | $1.0M | — | Filing → |